699 related articles for article (PubMed ID: 1674642)
1. Catecholamines in prevention of hypoglycemia during exercise in humans.
Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
[TBL] [Abstract][Full Text] [Related]
2. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
[TBL] [Abstract][Full Text] [Related]
3. Insulin and glucagon in prevention of hypoglycemia during exercise in humans.
Hirsch IB; Marker JC; Smith LJ; Spina RJ; Parvin CA; Holloszy JO; Cryer PE
Am J Physiol; 1991 May; 260(5 Pt 1):E695-704. PubMed ID: 2035626
[TBL] [Abstract][Full Text] [Related]
4. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE
Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952
[TBL] [Abstract][Full Text] [Related]
5. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting.
Boyle PJ; Shah SD; Cryer PE
Am J Physiol; 1989 May; 256(5 Pt 1):E651-61. PubMed ID: 2655471
[TBL] [Abstract][Full Text] [Related]
6. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.
Towler DA; Havlin CE; Craft S; Cryer P
Diabetes; 1993 Dec; 42(12):1791-8. PubMed ID: 8243825
[TBL] [Abstract][Full Text] [Related]
8. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
9. Evidence against important catecholamine compensation for absent glucagon counterregulation.
De Feo P; Perriello G; Torlone E; Fanelli C; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
Am J Physiol; 1991 Feb; 260(2 Pt 1):E203-12. PubMed ID: 1996624
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.
Rattarasarn C; Dagogo-Jack S; Zachwieja JJ; Cryer PE
Diabetes; 1994 Jun; 43(6):809-18. PubMed ID: 8194668
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
[TBL] [Abstract][Full Text] [Related]
12. Contribution of cortisol to glucose counterregulation in humans.
De Feo P; Perriello G; Torlone E; Ventura MM; Fanelli C; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
Am J Physiol; 1989 Jul; 257(1 Pt 1):E35-42. PubMed ID: 2665516
[TBL] [Abstract][Full Text] [Related]
13. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
Staten MA; Matthews DE; Cryer PE; Bier DM
Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829
[TBL] [Abstract][Full Text] [Related]
14. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.
Gosmanov NR; Szoke E; Israelian Z; Smith T; Cryer PE; Gerich JE; Meyer C
Diabetes Care; 2005 May; 28(5):1124-31. PubMed ID: 15855577
[TBL] [Abstract][Full Text] [Related]
15. GLP-1 does not not acutely affect insulin sensitivity in healthy man.
Orskov L; Holst JJ; Møller J; Orskov C; Møller N; Alberti KG; Schmitz O
Diabetologia; 1996 Oct; 39(10):1227-32. PubMed ID: 8897012
[TBL] [Abstract][Full Text] [Related]
16. The pancreatic-adrenocortical-pituitary clamp technique for study of counterregulation in humans.
De Feo P; Perriello G; Ventura MM; Brunetti P; Santeusanio F; Gerich JE; Bolli GB
Am J Physiol; 1987 Apr; 252(4 Pt 1):E565-70. PubMed ID: 2882686
[TBL] [Abstract][Full Text] [Related]
17. Prevention of overt hypoglycemia during exercise: stimulation of endogenous glucose production independent of hepatic catecholamine action and changes in pancreatic hormone concentration.
Coker RH; Koyama Y; Denny JC; Camacho RC; Lacy DB; Wasserman DH
Diabetes; 2002 May; 51(5):1310-8. PubMed ID: 11978626
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of a role for growth hormone in glucose counterregulation.
De Feo P; Perriello G; Torlone E; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
Am J Physiol; 1989 Jun; 256(6 Pt 1):E835-43. PubMed ID: 2567576
[TBL] [Abstract][Full Text] [Related]
19. Catecholamine responses and their interactions with other glucoregulatory hormones.
Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
[TBL] [Abstract][Full Text] [Related]
20. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
